Results 191 to 200 of about 15,146 (241)

Dose-sparing effects of novel adjuvants and aluminum hydroxide on two different vaccines in a neonatal mouse model. [PDF]

Front Immunol
Molina Estupiñan JL, Foroutan Pajoohian P, Pedersen GK, Christensen D, Marchi S, Montomoli E, Bjarnarson SP, Jonsdottir I, Aradottir Pind AA.   +8 more
europepmc   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Glycyrrhiza polysaccharide-adjuvanted liposomal vaccine potentiates tumor immunotherapy through lymph node-targeted modulation of the DC-T cell axis. [PDF]

J Exp Clin Cancer Res
Yao X, Zhang K, Zhang X, Lu S, Hu J, Wang Y, Lin J, Wu Y, Zhang W, Chen H, Liu X, Wang B, Luan X.   +12 more
europepmc   +1 more source

Lipid A mimetic BECC438 potentiates durable and balanced antibody responses in an ovalbumin murine model of vaccination. [PDF]

Immunohorizons
Harberts EM, Fields JK, Hunat JCS, Otteni DM, Gardner FM, Varisco DJ, Sundberg EJ, Snyder GA, Ernst RK.   +8 more
europepmc   +1 more source

mRNA and DNA-Based Vaccines in Genitourinary Cancers: A New Frontier in Personalized Immunotherapy. [PDF]

Vaccines (Basel)
Vohra J, Barbosa GR, Reis LO.
europepmc   +1 more source

Radiation-Induced Immune Responses from the Tumor Microenvironment to Systemic Immunity. [PDF]

Cancers (Basel)
Png S, Tadepalli S, Graves EE.
europepmc   +1 more source

Research Progress in the Development of Vaccines Against <i>Riemerella anatipestifer</i>. [PDF]

Microorganisms
Lan J, Wu S, Zhao L, Li F, Xing D, Li F, Tian H, Yang X, Sun S, Wang M.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Current Status of Immunological Adjuvants

Annual Review of Immunology, 1986
Sixty years ago Ramon demonstrated that it was possible to augment the antitoxin response to diphtheria and tetanus by administering vaccines with pyogenic bacteria or with various additional compounds (1). Since that time, clinicians and immunologists have sought to potentiate the immune response with adjuvants while attempting to minimize the often ...
H S, Warren, F R, Vogel, L A, Chedid
openaire   +3 more sources

Comparison of immunological adjuvants

APMIS, 2019
In this study, several innate immunological adjuvants and related compounds were compared with respect to complement activation in serum and induction of cytokine release in whole blood samples using immunoassays. As found, simple lipids had no effect on the complement system or on cytokine release, whereas lipopolysaccharides induced prominent release
Nicole H, Trier, Esin, Güven, Kristin, Skogstrand, Evaldas, Ciplys, Rimantas, Slibinskas, Gunnar, Houen   +5 more
openaire   +2 more sources